Quidel Is Said to Weigh Qiagen Deal as Medical M&A Quickens (1)

Feb. 8, 2021, 9:32 PM

Quidel Corp., the U.S. diagnostics firm, is weighing a combination with Qiagen NV in another sign of ongoing appetite for dealmaking in the medical equipment industry, people with knowledge of the matter said.

Quidel, which makes several types of coronavirus tests, has made a preliminary approach to Qiagen to gauge interest in a potential deal, the people said, asking not to be identified discussing confidential information.

Deliberations are at an early stage, and there’s no certainty they will result in a deal, the people said.

Qiagen’s U.S.-traded shares rose as much as 9.2% in New York Monday. The shares ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.